FDA ups the ante for copycats, antibiotics, orphan drugs. But is it working?

Deep inside last year's renewal of the Food and Drug Administration's user fee programs was a new type of drug designation, called Competitive Generic Therapy. To claim the title, a drug must enter a market where generic competition is lacking.